Abstract: We analyzed the earnings revision of HSCEI component stocks for August 2026, estimating the index's 2026E EPS at 795.9 as of end-August, up 0.13% month-on-month from 794.9 in July, with 27 stocks revised up versus 15 revised down. The HSCEI index declined 1.4% over the month from 8,612 to 8,490, while individual stock EPS revisions contributed an estimated HK$1.04 to the index's EPS change. The largest positive contributors to index EPS were China Life (2628 HK, +HK$2.85), Ping An (2318 HK, +HK$1.34), and BeOne Medicines (6160 HK, +HK$1.16), while Kuaishou (1024 HK, -HK$3.61), Xiaomi (1810 HK, -HK$1.88), and Baidu (9888 HK, -HK$1.35) were the largest detractors. On a percentage basis, Li Auto (2015 HK) and Xpeng (9868 HK) saw the sharpest EPS upgrades at +225% and +79.8% respectively, while Kuaishou (-34.3%), Pop Mart (9992 HK, -17.7%), and Baidu (-15.5%) suffered the steepest EPS cuts.
CSPC PHARMA, Kuaishou, Pop Mart Intl, SHENZHOU INTERNATIONAL, PING AN, XPENG
Interested in the full report? Get in touch with our team.